EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine

Click For Larger Image & Read More
EMA recommends approval of VidPrevtyn Beta as a...
 © PIO (Official) 2023

EMA’s human medicines committee (CHMP) has recommended authorising the COVID-19 vaccine VidPrevtyn Beta as a booster in adults previously vaccinated with an mRNA or adenoviral vector COVID-19 vaccine.

VidPrevtyn Beta, developed by Sanofi Pasteur, contains a version of the spike protein found on the surface of the Beta variant of the SARS-CoV-2 virus. It also contains an ‘adjuvant’, a substance to help strengthen the immune responses to the vaccine.

EMA’s human medicines committee (CHMP) concluded that sufficiently robust data on the quality, safety and immunogenicity of the vaccine are now available to recommend its marketing authorisation in the EU.

The main studies conducted with VidPrevtyn Beta are two immunobridging trials, which compare the immune response induced by this new vaccine with that induced by an authorised comparator vaccine effective against the disease...

 


Click to view: Cyprus Vaccination News - Live

Article automatically added to our system on Thursday, November 24, 2022

EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine


Contents of this article including associated images are © PIO (Official) 2023
Views & opinions expressed are those of the author and/or PIO (Official) .

Article Tags: #recommends   #approval   #vidprevtyn   #covid   #booster   #vaccine  


Advertise Here